annual FCF:
-$117.11M-$74.04M(-171.94%)Summary
- As of today (June 17, 2025), MLTX annual free cash flow is -$117.11 million, with the most recent change of -$74.04 million (-171.94%) on December 31, 2024.
- MLTX annual FCF is now -171.94% below its all-time high of -$43.06 million, reached on December 31, 2023.
Performance
MLTX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$38.17M+$10.47M(+21.53%)Summary
- As of today (June 17, 2025), MLTX quarterly free cash flow is -$38.17 million, with the most recent change of +$10.47 million (+21.53%) on March 31, 2025.
- Over the past year, MLTX quarterly FCF has dropped by -$23.02 million (-151.81%).
- MLTX quarterly FCF is now -323.02% below its all-time high of -$9.02 million, reached on March 31, 2023.
Performance
MLTX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$140.12M-$23.02M(-19.65%)Summary
- As of today (June 17, 2025), MLTX TTM free cash flow is -$140.12 million, with the most recent change of -$23.02 million (-19.65%) on March 31, 2025.
- Over the past year, MLTX TTM FCF has dropped by -$91.21 million (-186.47%).
- MLTX TTM FCF is now -886.63% below its all-time high of -$14.20 million, reached on March 31, 2022.
Performance
MLTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
MLTX Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -171.9% | -151.8% | -186.5% |
| 3 y3 years | - | -168.8% | -886.6% |
| 5 y5 years | - | - | - |
MLTX Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -171.9% | at low | -323.0% | +21.5% | -886.6% | at low |
| 5 y | 5-year | -171.9% | at low | -323.0% | +21.5% | -886.6% | at low |
| alltime | all time | -171.9% | at low | -323.0% | +21.5% | -886.6% | at low |
MLTX Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$38.17M(-21.5%) | -$140.12M(+19.7%) |
| Dec 2024 | -$117.11M(+171.9%) | -$48.65M(+91.5%) | -$117.11M(+44.9%) |
| Sep 2024 | - | -$25.41M(-8.9%) | -$80.80M(+25.0%) |
| Jun 2024 | - | -$27.89M(+84.0%) | -$64.65M(+32.2%) |
| Mar 2024 | - | -$15.16M(+22.8%) | -$48.91M(+14.3%) |
| Dec 2023 | -$43.06M | -$12.34M(+33.4%) | -$42.78M(+1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$9.25M(-23.9%) | -$42.03M(-0.2%) |
| Jun 2023 | - | -$12.16M(+34.7%) | -$42.13M(-17.0%) |
| Mar 2023 | - | -$9.02M(-22.2%) | -$50.73M(-9.3%) |
| Dec 2022 | -$55.91M | -$11.60M(+24.0%) | -$55.91M(+26.2%) |
| Sep 2022 | - | -$9.35M(-55.0%) | -$44.31M(+26.7%) |
| Jun 2022 | - | -$20.76M(+46.2%) | -$34.96M(+146.2%) |
| Mar 2022 | - | -$14.20M | -$14.20M |
FAQ
- What is MoonLake Immunotherapeutics annual free cash flow?
- What is the all time high annual FCF for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual FCF year-on-year change?
- What is MoonLake Immunotherapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly FCF year-on-year change?
- What is MoonLake Immunotherapeutics TTM free cash flow?
- What is the all time high TTM FCF for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM FCF year-on-year change?
What is MoonLake Immunotherapeutics annual free cash flow?
The current annual FCF of MLTX is -$117.11M
What is the all time high annual FCF for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual free cash flow is -$43.06M
What is MoonLake Immunotherapeutics annual FCF year-on-year change?
Over the past year, MLTX annual free cash flow has changed by -$74.04M (-171.94%)
What is MoonLake Immunotherapeutics quarterly free cash flow?
The current quarterly FCF of MLTX is -$38.17M
What is the all time high quarterly FCF for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly free cash flow is -$9.02M
What is MoonLake Immunotherapeutics quarterly FCF year-on-year change?
Over the past year, MLTX quarterly free cash flow has changed by -$23.02M (-151.81%)
What is MoonLake Immunotherapeutics TTM free cash flow?
The current TTM FCF of MLTX is -$140.12M
What is the all time high TTM FCF for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM free cash flow is -$14.20M
What is MoonLake Immunotherapeutics TTM FCF year-on-year change?
Over the past year, MLTX TTM free cash flow has changed by -$91.21M (-186.47%)